TITLE
Adriamycin in vitro effect on Eµ-myc transgenic lymphoma cells deficient in Suv39h1

SUMMARY
Analysis of lymphoma cells isolated from Eµ-myc mice deficient in H3K9 histone methyltransferase Suv39h1 and treated in vitro with anticancer drug ADR. ADR induces therapy-induced senescence (TIS) in Suv39h1-proficient lymphomas. Results provide insight into the impact of Suv39h1 on TIS induction.

ORGANISM
Mus musculus

PLATFORM
GPL1261 : [Mouse430_2] Affymetrix Mouse Genome 430 2.0 Array

CITATIONS
Dörr JR, Yu Y, Milanovic M, Beuster G et al. Synthetic lethal metabolic targeting of cellular senescence in cancer therapy. Nature 2013 Sep 19;501(7467):421-5. PMID:  23945590

